Learn more about kisqali-200-mg-dose
Kisqali (200 Mg Dose) is a Cyclin-Dependent Kinases (CDK) Inhibitors class drug made by NOVARTIS. The typical out-of-pocket price for Kisqali (200 Mg Dose) is $10,424.99 per 1, 21 tablets therapy pack box, but you can pay $7,315.98 for 1, 21 tablets therapy pack box of Kisqali (200 Mg Dose) with your SingleCare discount card.
This is a limited availability drug and is not available at most pharmacies
We recommend contacting your insurance company about the availability of this drug.
About Kisqali (200 Mg Dose)
Kisqali (200 Mg Dose) is a Cyclin-Dependent Kinases (CDK) Inhibitors class drug made by NOVARTIS. The typical out-of-pocket price for Kisqali (200 Mg Dose) is $10,424.99 per 1, 21 tablets therapy pack box, but you can pay $7,315.98 for 1, 21 tablets therapy pack box of Kisqali (200 Mg Dose) with your SingleCare discount card.
About Kisqali (200 Mg Dose)
Kisqali (200 Mg Dose) is a Cyclin-Dependent Kinases (CDK) Inhibitors class drug made by NOVARTIS. The typical out-of-pocket price for Kisqali (200 Mg Dose) is $10,424.99 per 1, 21 tablets therapy pack box, but you can pay $7,315.98 for 1, 21 tablets therapy pack box of Kisqali (200 Mg Dose) with your SingleCare discount card.
Subscribe to our savings newsletter
Health education, drug info, wellness & more
By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.
